Clinical Trial: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07044349) titled 'Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer' on June 23.

Brief Summary: This is an open, multicenter, phase II clinical study enrolling patients with platinum-resistant advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer to evaluate the safety and efficacy of Utidelone Capsules. Approximately 72 patients will be included in this study.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Intervention: DRUG: Utidelone capsule 75mg/m2...